Schonfeld Strategic Advisors LLC - Dec 31, 2024 SCHEDULE 13G/A Report for Terns Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share (TERN)

Filing Manager: Schonfeld Strategic Advisors LLC
Reporting Manager: Schonfeld Strategic Advisors LLC
Security: Terns Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share
Symbol: TERN
Shares outstanding: 85M shares
Disclosed Ownership: 5.23M shares
Ownership: 6.16%
Form type: SCHEDULE 13G/A
Date filed: 2/14/2025, 04:15 PM
Date of event: Dec 31, 2024
Next filing: May 15, 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Schonfeld Strategic Advisors LLC	6.16%	5.23M	5.23M	0	/s/ Mark H. Peckman	Mark H. Peckman/General Counsel and Chief Compliance Officer